79377981 - DERMATOPLEX

Information

• Trademark
• 79377981

• Source

• Serial Number

  79377981

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  July 31, 2023
  a year ago

• Transaction Date

  May 17, 2025
  11 days ago

• Status Date

  May 15, 2025
  13 days ago

• Published for Opposition Date

  June 03, 2025
  5 days from now

• Location Date

  May 15, 2025
  13 days ago

• Status Code

  681

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  VENGURLEKAR, SAGAR

• Attorney Docket Number

  T-5106 US MP

  Attorney Name

  Jefferson F. Scher

  Law Office Assigned Location Code

  M80

• Owners

  • SpeeDx Pty Ltd

Case File Statements

• DM0000: The mark consists of the stylized wording "DERMATOPLEX".
• GS0051: Reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use to identify pathogens, infections, and infectious diseases; chemical preparations containing enzymes for medical purposes for treating infections and infectious diseases; chemical preparations containing enzymes for treating infections and infectious diseases for pharmaceutical, veterinary and medical purposes; enzyme preparations for pharmaceutical, veterinary and medical purposes; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; diagnostic kits comprising diagnostic agents, preparations and substances for medical and veterinary use; diagnostic kits comprised of medical diagnostic reagents and assays for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders, all for testing of bodily fluids for use in disease detection, namely, to diagnose and identify pathogens, infections, and infectious diseases; none of the foregoing for use in or as a medicated shampoo
• GS0011: Chemical reagents for non-medical purposes; chemical reagents for scientific purposes; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; enzyme preparations for industrial purposes to identify pathogens, infections, and infectious diseases; enzymes for scientific and research purposes; nucleic acids for scientific purposes; nucleic recombinant acids for scientific purposes; acids, namely, nucleic recombinant acids to identify pathogens, infections, and infectious diseases for scientific purposes; polymerase for scientific purposes; none of the foregoing for use in promoting plant growth or in enhancing the effectiveness of plant nutrients
• GS0441: Medical services; human healthcare services in the field of diagnosis and identification of pathogens infections and infectious diseases; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services in the field of DNA and genetic testing; medical diagnostic services in the nature of medical testing and analysis; molecular diagnostics testing for medical purposes; providing medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; analysis of medical diagnostic images and medical molecular tests for medical purposes
• GS0101: Surgical, medical and veterinary apparatus and instruments for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; diagnostic testing apparatus and instruments for medical purposes, namely, for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; medical diagnostic apparatus for testing for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; point of care medical devices, namely, a device for testing for diagnosis of disease, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, analysis of response to therapy for treatment of infectious diseases, immunological diseases and autoimmune diseases; diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Anatomic pathology specimen collection kit comprising glass slides, centrifuge tubes, formalin jars, coplin jars, insert to hold slides and jars, absorbent cloth, and printed instructions, all for medical use
• GS0421: Scientific research in the field of genetics; scientific research in the field of genetics and genetic engineering; research and development services in the field of chemistry; scientific research in the field of chemistry; research in the field of chemistry; research laboratory analysis services in the field of chemistry; development services in the field of medical diagnostic apparatuses; design of medical diagnostic apparatuses; research in the field of molecular sciences; data analysis for scientific research purposes in the field of scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services, for scientific research purposes; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services for scientific research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom for scientific research purposes; providing reports relating to scientific and medical experiments, the results of scientific and medical experiments and tests, the analysis and evaluation of scientific and medical data, and data generated by scientific and medical experiments and tests; scientific and medical research and development services, for scientific research purposes; custom design and development of biochemical assays

Case File Event Statements

• 9/7/2023 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 9/8/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/12/2023 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 4/1/2024 - a year ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 4/3/2024 - a year ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/4/2024 - a year ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 4/23/2024 - a year ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 4/24/2024 - a year ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 5/12/2024 - a year ago

  9 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG

• 5/13/2024 - a year ago

  10 - REFUSAL PROCESSED BY IB Type: RFNT

• 7/7/2024 - 10 months ago

  11 - LIMITATION FROM THE IB - REQUEST EXAM REVIEW Type: LIME

• 10/22/2024 - 7 months ago

  16 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/12/2024 - 9 months ago

  12 - ATTORNEY REVIEW COMPLETED Type: ATRV

• 10/22/2024 - 7 months ago

  17 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR

• 10/22/2024 - 7 months ago

  13 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 10/22/2024 - 7 months ago

  14 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 10/22/2024 - 7 months ago

  15 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 10/22/2024 - 7 months ago

  18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 10/23/2024 - 7 months ago

  20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/23/2024 - 7 months ago

  21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/23/2024 - 7 months ago

  19 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/11/2025 - 3 months ago

  26 - FINAL REFUSAL E-MAILED Type: GNFR

• 1/13/2025 - 4 months ago

  22 - ASSIGNED TO EXAMINER Type: DOCK

• 2/9/2025 - 3 months ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 2/10/2025 - 3 months ago

  24 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 5/4/2025 - 24 days ago

  30 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 5/4/2025 - 24 days ago

  29 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR

• 5/4/2025 - 24 days ago

  31 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 2/11/2025 - 3 months ago

  25 - FINAL REFUSAL WRITTEN Type: CNFR

• 2/11/2025 - 3 months ago

  27 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 3/1/2025 - 2 months ago

  28 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 5/5/2025 - 23 days ago

  32 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA